Dexamethasone stimulates the expression of ghrelin and its receptor in rat hypothalamic 4B cells

Regulatory Peptides

Volumn 174, Issue 1-3, 2012, Pages 12-17

  Kageyama, Kazunori ^a   Akimoto, Kanako ^a   Yamagata, Satoshi ^a   Sugiyama, Aya ^a   Murasawa, Shingo ^a   Watanuki, Yutaka ^a   Tamasawa, Naoki ^a   Suda, Toshihiro ^a  

^a HIROSAKI UNIVERSITY   (Japan)

Author keywords

Corticotropin releasing factor; Ghrelin; Glucocorticoids; Hypothalamus

Indexed keywords

CORTICOTROPIN RELEASING FACTOR; DEXAMETHASONE; GHRELIN; GHRELIN RECEPTOR; MESSENGER RNA; MIFEPRISTONE;

ANIMAL CELL; ARTICLE; CELL LEVEL; CELL STIMULATION; CONTROLLED STUDY; FETUS; GENE EXPRESSION REGULATION; HORMONAL REGULATION; HORMONE RELEASE; HYPOTHALAMIC PARAVENTRICULAR NUCLEUS; NERVE CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CELLS, CULTURED; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GHRELIN; HYPOTHALAMUS; RATS; REAL-TIME POLYMERASE CHAIN REACTION; RECEPTORS, GHRELIN; RNA, MESSENGER; STRUCTURE-ACTIVITY RELATIONSHIP;

RATTUS;

EID: 84856488643     PISSN: 01670115     EISSN: 18731686     Source Type: Journal    
DOI: 10.1016/j.regpep.2011.11.003     Document Type: Article

References (31)

1. Bowers C.Y. GH releasing peptides-structure and kinetics. J Pediatr Endocrinol 1993, 6:21-31.
2. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
3. Gondo R.G., Aguiar-Oliveira M.H., Hayashida C.Y., Toledo S.P., Abelin N., Levine M.A., Bowers C.Y., Souza A.H., Pereira R.M., Santos N.L., Salvatori R. Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor. J Clin Endocrinol Metab 2001, 86:3279-3283.
4. Takaya K., Ariyasu H., Kanamoto N., Iwakura H., Yoshimoto A., Harada M., Mori K., Komatsu Y., Usui T., Shimatsu A., Ogawa Y., Hosoda K., Akamizu T., Kojima M., Kangawa K., Nakao K. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 2000, 85:4908-4911.
5. Mozid A.M., Tringali G., Forsling M.L., Hendricks M.S., Ajodha S., Edwards R., Navarra P., Grossman A.B., Korbonits M. Ghrelin is released from rat hypothalamic explants and stimulates corticotrophin-releasing hormone and arginine-vasopressin. Horm Metab Res 2003, 35:455-459.
6. Korbonits M., Little J.A., Forsling M.L., Tringali G., Costa A., Navarra P., Trainer P.J., Grossman A.B. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. J Neuroendocrinol 1999, 11:521-528.
7. Sakihara S., Kageyama K., Matsumoto A., lkeda H., Tsushima Y., Naraoka M., Terui K., Nigawara T., Suda T. Exaggerated response of adrenocorticotropic hormone to growth hormone-releasing peptide-2 test in Cushing's disease. Neurol Med Chir (Tokyo) 2009, 49:364-368.
8. Kageyama K., Kumada Y., Akimoto K., Takayasu S., Tamasawa N., Suda T. Ghrelin stimulates corticotropin-releasing factor and vasopressin gene expression in rat hypothalamic 4B cells. Stress 2011, 14:520-529.
9. Howard A.D., Feighner S.D., Cully D.F., Arena J.P., Liberator P.A., Rosenblum C.I., Hamelin M., Hreniuk D.L., Palyha O.C., Anderson J., Paress P.S., Diaz C., Chou M., Liu K.K., McKee K.K., Pong S.S., Chaung L.Y., Elbrecht A., Dashkevicz M., Heavens R., Rigby M., Sirinathsinghji D.J., Dean D.C., Melillo D.G., Patchett A.A., Nargund R., Griffin P.R., DeMartino J.A., Gupta S.K., Schaeffer J.M., Smith R.G., Van der Ploeg L.H. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 1996, 273:974-977.
10. Camilleri M., Papathanasopoulos A., Odunsi S.T. Actions and therapeutic pathways of ghrelin for gastrointestinal disorders. Nat Rev Gastroenterol Hepatol 2009, 6:343-352.
11. Gasco V., Beccuti G., Marotta F., Benso A., Granata R., Broglio F., Ghigo E. Endocrine and metabolic actions of ghrelin. Endocr Dev 2010, 17:86-95.
12. Horvath T.L., Diano S., Sotonyi P., Heiman M., Tschöp M. Minireview: ghrelin and the regulation of energy balance-a hypothalamic perspective. Endocrinology 2001, 142:4163-4169.
13. Kawashima S., Sakihara S., Kageyama K., Nigawara T., Suda T. Corticotropin-releasing factor (CRF) is involved in the acute anorexic effect of a-melanocyte-stimulating hormone: a study using CRF-deficient mice. Peptides 2008, 29:2169-2174.
14. Whitnall M.H. Regulation of the hypothalamic corticotropin-releasing hormone neurosecretory system. Prog Neurobiol 1993, 40:573-629.
15. Uht R.M., McKelvy J.F., Harrison R.W., Bohn M.C. Demonstration of glucocorticoid receptor-like immunoreactivity in glucocorticoid-sensitive vasopressin and corticotropin-releasing factor neurons in the hypothalamic paraventricular nucleus. J Neurosci Res 1988, 19(405-11):468-469.
16. Ceccatelli S., Cintra A., Hökfelt T., Fuxe K., Wikström A.C., Gustafsson J.A. Coexistence of glucocorticoid receptor-like immunoreactivity with neuropeptides in the hypothalamic paraventricular nucleus. Exp Brain Res 1989, 78:33-42.
17. Kageyama K., Tamasawa N., Suda T. Signal transduction in the hypothalamic corticotropin-releasing factor system and its clinical implications. Stress 2011, 14:57-67.
18. Bali B., Ferenczi S., Kovács K.J. Direct inhibitory effect of glucocorticoids on corticotrophin-releasing hormone gene expression in neurones of the paraventricular nucleus in rat hypothalamic organotypic cultures. J Neuroendocrinol 2008, 20:1045-1051.
19. Sawchenko P.E., Swanson L.W., Vale W.W. Corticotropin-releasing factor: co-expression within distinct subsets of oxytocin-, vasopressin-, and neurotensin-immunoreactive neurons in the hypothalamus of the male rat. J Neurosci 1984, 4:1118-1129.
20. Young W.S., Mezey E., Siegel R.E. Quantitative in situ hybridization histochemistry reveals increased levels of corticotropin-releasing factor mRNA after adrenalectomy in rats. Neurosci Lett 1986, 70:198-203.
21. Kageyama K., Akimoto K., Suda T. Corticotropin-releasing factor gene transcription is directly activated after deprivation of glucocorticoids in hypothalamic cells. J Neuroendocrinol 2010, 22:971-978.
22. Kasckow J., Mulchahey J.J., Aguilera G., Pisarska M., Nikodemova M., Chen H.C., Herman J.P., Murphy E.K., Liu Y., Rizvi T.A., Dautzenberg F.M., Sheriff S. Corticotropin-releasing hormone (CRH) expression and protein kinase A mediated CRH receptor signalling in an immortalized hypothalamic cell line. J Neuroendocrinol 2003, 15:521-529.
23. Gauna C., Delhanty P.J., van Aken M.O., Janssen J.A., Themmen A.P., Hofland L.J., Culler M., Broglio F., Ghigo E., van der Lely A.J. Unacylated ghrelin is active on the INS-1E rat insulinoma cell line independently of the growth hormone secretagogue receptor type 1a and the corticotropin releasing factor 2 receptor. Mol Cell Endocrinol 2006, 251:103-111.
24. Kamegai J., Tamura H., Ishii S., Sugihara H., Wakabayashi I. Thyroid hormones regulate pituitary growth hormone secretagogue receptor gene expression. J Neuroendocrinol 2001, 13:275-278.
25. Kineman R.D., Kamegai J., Frohman L.A. Growth hormone (GH)-releasing hormone (GHRH) and the GH secretagogue (GHS), L692,585, differentially modulate rat pituitary GHS receptor and GHRH receptor messenger ribonucleic acid levels. Endocrinology 1999, 140:3581-3586.
26. Wren A.M., Small C.J., Fribbens C.V., Neary N.M., Ward H.L., Seal L.J., Ghatei M.A., Bloom S.R. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 2002, 76:316-324.
27. King B.M. Glucocorticoids and hypothalamic obesity. Neurosci Biobehav Rev 1988, 12:29-37.
28. Anagnostis P., Athyros V.G., Tziomalos K., Karagiannis A., Mikhailidis D.P. Clinical review: the pathogenetic role of cortisol in the metabolic syndrome: a hypothesis. J Clin Endocrinol Metab 2009, 94:2692-2701.
29. Chan O., Inouye K., Riddell M.C., Vranic M., Matthews S.G. Diabetes and the hypothalamo-pituitary-adrenal (HPA) axis. Minerva Endocrinol 2003, 28:87-102.
30. Chiodini I., Torlontano M., Scillitani A., Arosio M., Bacci S., Di Lembo S., Epaminonda P., Augello G., Enrini R., Ambrosi B., Adda G., Trischitta V. Association of subclinical hypercortisolism with type 2 diabetes mellitus: a case-control study in hospitalized patients. Eur J Endocrinol 2005, 153:837-844.
31. Chen C.Y., Fujimiya M., Laviano A., Chang F.Y., Lin H.C., Lee S.D. Modulation of ingestive behavior and gastrointestinal motility by ghrelin in diabetic animals and humans. J Chin Med Assoc 2010, 73:225-229.